DDInter158 DDInter1951
A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.
Warfarin is an anticoagulant drug normally used to prevent blood clot formation as well as migration. Although originally marketed as a pesticide (d-Con, Rodex, among others), Warfarin has since become the most frequently prescribed oral anticoagulant in North America. Warfarin has several properties that should be noted when used medicinally, including its ability to cross the placental barrier during pregnancy which can result in fetal bleeding, spontaneous abortion, preterm birth, stillbirth, and neonatal death. Additional adverse effects such as necrosis, purple toe syndrome, osteoporosis, valve and artery calcification, and drug interactions have also been documented with warfarin use. Warfarin does not actually affect blood viscosity, rather, it inhibits vitamin-k dependent synthesis of biologically active forms of various clotting factors in addition to several regulatory factors.
Aztreonam {u} (Compound) resembles {v} (Compound) Ceftizoxime
Ceftizoxime {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Warfarin
Aztreonam {u} (Compound) resembles {v} (Compound) Cefotaxime
Cefotaxime {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Warfarin
Aztreonam {u} (Compound) resembles {v} (Compound) Cefixime
Cefixime {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Warfarin
Aztreonam {u} (Compound) resembles {v} (Compound) Ceftizoxime
Ceftizoxime {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Chloramphenicol
Chloramphenicol {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Warfarin
Aztreonam {u} (Compound) resembles {v} (Compound) Ceftazidime
Ceftazidime {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Methotrexate
Methotrexate {u} may cause a minor interaction that can limit clinical effects when taken with {v} Warfarin
Aztreonam {u} (Compound) downregulates {v} (Gene) UBQLN2
UBQLN2 {u} (Gene) is upregulated by {v} (Compound) Ifosfamide
Ifosfamide {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Warfarin
Aztreonam {u} (Compound) resembles {v} (Compound) Cefixime
Cefixime {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Chloramphenicol
Chloramphenicol {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Warfarin
Aztreonam {u} (Compound) resembles {v} (Compound) Ceftizoxime
Ceftizoxime {u} (Compound) resembles {v} (Compound) Cefepime
Cefepime {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Warfarin
Aztreonam {u} (Compound) resembles {v} (Compound) Cefpodoxime
Cefpodoxime {u} (Compound) resembles {v} (Compound) Ceftizoxime
Ceftizoxime {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Warfarin
Aztreonam {u} (Compound) resembles {v} (Compound) Ceftazidime
Ceftazidime {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Chloramphenicol
Chloramphenicol {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Warfarin
Aztreonam (Compound) resembles Ceftizoxime (Compound) and Ceftizoxime may cause a moderate interaction that could exacerbate diseases when taken with Warfarin
Aztreonam (Compound) resembles Cefotaxime (Compound) and Cefotaxime may cause a moderate interaction that could exacerbate diseases when taken with Warfarin
Aztreonam (Compound) resembles Cefixime (Compound) and Cefixime may cause a moderate interaction that could exacerbate diseases when taken with Warfarin
Aztreonam (Compound) resembles Ceftizoxime (Compound) and Ceftizoxime may cause a moderate interaction that could exacerbate diseases when taken with Chloramphenicol and Chloramphenicol may cause a moderate interaction that could exacerbate diseases when taken with Warfarin
Aztreonam (Compound) resembles Ceftazidime (Compound) and Ceftazidime may cause a moderate interaction that could exacerbate diseases when taken with Methotrexate and Methotrexate may cause a minor interaction that can limit clinical effects when taken with Warfarin
Aztreonam (Compound) downregulates UBQLN2 (Gene) and UBQLN2 (Gene) is upregulated by Ifosfamide (Compound) and Ifosfamide may cause a moderate interaction that could exacerbate diseases when taken with Warfarin
Aztreonam (Compound) resembles Cefixime (Compound) and Cefixime may cause a moderate interaction that could exacerbate diseases when taken with Chloramphenicol and Chloramphenicol may cause a moderate interaction that could exacerbate diseases when taken with Warfarin
Aztreonam (Compound) resembles Ceftizoxime (Compound) and Ceftizoxime (Compound) resembles Cefepime (Compound) and Cefepime may cause a moderate interaction that could exacerbate diseases when taken with Warfarin
Aztreonam (Compound) resembles Cefpodoxime (Compound) and Cefpodoxime (Compound) resembles Ceftizoxime (Compound) and Ceftizoxime may cause a moderate interaction that could exacerbate diseases when taken with Warfarin
Aztreonam (Compound) resembles Ceftazidime (Compound) and Ceftazidime may cause a moderate interaction that could exacerbate diseases when taken with Chloramphenicol and Chloramphenicol may cause a moderate interaction that could exacerbate diseases when taken with Warfarin